206 related articles for article (PubMed ID: 25492964)
21. Uncoupling of the Hippo and Rho pathways allows megakaryocytes to escape the tetraploid checkpoint.
Roy A; Lordier L; Pioche-Durieu C; Souquere S; Roy L; Rameau P; Lapierre V; Le Cam E; Plo I; Debili N; Raslova H; Vainchenker W
Haematologica; 2016 Dec; 101(12):1469-1478. PubMed ID: 27515249
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of Hippo pathway regulation.
Meng Z; Moroishi T; Guan KL
Genes Dev; 2016 Jan; 30(1):1-17. PubMed ID: 26728553
[TBL] [Abstract][Full Text] [Related]
23. Activation of Yap-Directed Transcription by Knockdown of Conserved Cellular Functions.
Agarinis C; Orsini V; Megel P; Abraham Y; Yang H; Mickanin C; Myer V; Bouwmeester T; Tchorz JS; Parker CN
J Biomol Screen; 2016 Mar; 21(3):269-76. PubMed ID: 26637552
[TBL] [Abstract][Full Text] [Related]
24. Interaction of the EGF Receptor and the Hippo Pathway in the Diabetic Kidney.
Chen J; Harris RC
J Am Soc Nephrol; 2016 Jun; 27(6):1689-700. PubMed ID: 26453611
[TBL] [Abstract][Full Text] [Related]
25. Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer.
Song R; Gu D; Zhang L; Zhang X; Yu B; Liu B; Xie J
Mol Carcinog; 2018 Nov; 57(11):1608-1615. PubMed ID: 30074279
[TBL] [Abstract][Full Text] [Related]
26. Immunohistochemistry to Study YAP in Human Tissue Samples.
Haderk F; Olivas V; Bivona TG
Methods Mol Biol; 2019; 1893():89-95. PubMed ID: 30565127
[TBL] [Abstract][Full Text] [Related]
27. Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells.
Wali VB; Haskins JW; Gilmore-Hebert M; Platt JT; Liu Z; Stern DF
Mol Cancer Res; 2014 Aug; 12(8):1140-55. PubMed ID: 24829397
[TBL] [Abstract][Full Text] [Related]
28. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis.
Zhao B; Li L; Wang L; Wang CY; Yu J; Guan KL
Genes Dev; 2012 Jan; 26(1):54-68. PubMed ID: 22215811
[TBL] [Abstract][Full Text] [Related]
29. The role of ErbB4 in cancer.
Segers VFM; Dugaucquier L; Feyen E; Shakeri H; De Keulenaer GW
Cell Oncol (Dordr); 2020 Jun; 43(3):335-352. PubMed ID: 32219702
[TBL] [Abstract][Full Text] [Related]
30. Hippo circuitry and the redox modulation of hippo components in cancer cell fate decisions.
Ashraf A; Pervaiz S
Int J Biochem Cell Biol; 2015 Dec; 69():20-8. PubMed ID: 26456518
[TBL] [Abstract][Full Text] [Related]
31. Knockdown of the Hippo transducer YAP reduces proliferation and promotes apoptosis in the Jurkat leukemia cell.
Wu R; Yang H; Wan J; Deng X; Chen L; Hao S; Ma L
Mol Med Rep; 2018 Dec; 18(6):5379-5388. PubMed ID: 30320399
[TBL] [Abstract][Full Text] [Related]
32. Analysis of regulatory mechanism after ErbB4 gene mutation based on local modeling methodology.
Chen CL; Zhao JW
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323039
[TBL] [Abstract][Full Text] [Related]
33. Neuregulin1 alpha activates migration of neuronal progenitors expressing ErbB4.
Fornasari BE; El Soury M; De Marchis S; Perroteau I; Geuna S; Gambarotta G
Mol Cell Neurosci; 2016 Dec; 77():87-94. PubMed ID: 27989735
[TBL] [Abstract][Full Text] [Related]
34. Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer.
Adashek JJ; Pandya C; Maragakis NJ; De P; Cohen PR; Kato S; Kurzrock R
BMC Med; 2024 Feb; 22(1):74. PubMed ID: 38369520
[TBL] [Abstract][Full Text] [Related]
35. Dishevelling Wnt and Hippo.
Kim NH; Lee Y; Yook JI
BMB Rep; 2018 Sep; 51(9):425-426. PubMed ID: 30078391
[TBL] [Abstract][Full Text] [Related]
36. Increased NRG1-ErbB4 signaling in human symptomatic epilepsy.
Zhu JM; Li KX; Cao SX; Chen XJ; Shen CJ; Zhang Y; Geng HY; Chen BQ; Lian H; Zhang JM; Li XM
Sci Rep; 2017 Mar; 7(1):141. PubMed ID: 28273943
[TBL] [Abstract][Full Text] [Related]
37. [Research progress of neuregulin 4 biological function].
Yang F; Li XN
Sheng Li Xue Bao; 2017 Jun; 69(3):351-356. PubMed ID: 28638929
[TBL] [Abstract][Full Text] [Related]
38. Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer.
Mori M; Triboulet R; Mohseni M; Schlegelmilch K; Shrestha K; Camargo FD; Gregory RI
Cell; 2014 Feb; 156(5):893-906. PubMed ID: 24581491
[TBL] [Abstract][Full Text] [Related]
39. STAT5b is a key effector of NRG-1/ERBB4-mediated myocardial growth.
Vaparanta K; Jokilammi A; Paatero I; Merilahti JA; Heliste J; Hemanthakumar KA; Kivelä R; Alitalo K; Taimen P; Elenius K
EMBO Rep; 2023 May; 24(5):e56689. PubMed ID: 37009825
[TBL] [Abstract][Full Text] [Related]
40. Differential changes in Neuregulin-1 signaling in major brain regions in a lipopolysaccharide-induced neuroinflammation mouse model.
Yang Z; Jiang Q; Chen SX; Hu CL; Shen HF; Huang PZ; Xu JP; Mei JP; Zhang BP; Zhao WJ
Mol Med Rep; 2016 Jul; 14(1):790-6. PubMed ID: 27220549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
